Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

Aspen Neuroscience’s stem cell therapy improved Parkinson’s disease symptoms for all eight treated patients after one year, with the San Diego biotech now planning for a pivotal phase 3 trial later ...

Japan’s health ministry has endorsed two stem-cell therapies derived from induced pluripotent stem (iPS) cells, making them the first treatments of their kind to clear a national regulatory body ...

Amid advances in medicine to improve people's quality of life, an Osaka Metropolitan University-led team has, for the first time in the world, generated high-quality feline induced pluripotent stem ...

DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cells Market" report has been added to ResearchAndMarkets.com's offering. The Induced Pluripotent Stem Cells Market was valued at USD 3.4 billion ...

Stem cells, particularly Induced Pluripotent Stem Cells (iPSCs), are becoming essential tools in scientific research, from drug discovery to disease modeling. As the scientific community shifts away ...

Scientists in Zurich have shown that stem cell transplants can reverse stroke damage by regenerating neurons, restoring motor functions, and even repairing blood vessels. The breakthrough not only ...

Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.

The patent relates to potency assay methods for assessing human mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue, peripheral blood, a lung, a heart, amniotic fluid, inner organs, ...

The big picture: Nearly two decades ago, Shinya Yamanaka and Kazutoshi Takahashi discovered they could turn mature somatic cells back into stem cells. The scientists predicted these new cells could be ...